Relevant bibliographies by topics / Blueprint A 3.0

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Blueprint A 3.0'

Author: Grafiati
Published: 24 June 2021
Last updated: 18 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Blueprint A 3.0.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Blueprint A 3.0"

1

Bocchi, V., M. G. Strillacci, A. Zecconi, C. Galli, G. Stadaioli, T. A. L. Brevini, A. Bagnato, and F. Gandolfi. "191 SEARCHING FOR THE IN VIVO TRANSCRIPTOME BLUEPRINT OF COMPETENT BOVINE OOCYTES." Reproduction, Fertility and Development 28, no. 2 (2016): 226. http://dx.doi.org/10.1071/rdv28n2ab191.

Full text
Abstract:
Gene expression in early stage embryos relies mostly on post-transcriptional control of maternal transcripts accumulated during oocyte maturation. However, while the building process to obtain a competent oocyte is now better understood, it is still not clear what transcriptome blueprint composes a competent oocyte. The aim of the study was to compare the mRNA expression pattern between oocytes collected from fertile heifers and repeat breeders by using RNAseq. Oocytes were collected by ovum pickup from 3 heifers that were 11–15 months of age and became pregnant at the following oestrus and from 4 adult cows with an age of 4 to 7 years, classified as repeat breeders after they failed to become pregnant for a minimum of 3 consecutive AI. To obtain oocytes from follicles with the same degree of development, at time 0 all follicles visible through transrectal ultrasound examination were removed by transvaginal aspiration. Five days later oocytes were collected by ovum pick up from the newly formed follicles with diameters >5 mm. Oocytes from each animal were pooled and sequenced as a single sample. Total RNA was extracted by RNeasy Micro Kit (Qiagen, Valencia, CA, USA). Amplified cDNA, was prepared starting from total RNA using the Ovation RNA-Seq System V2 (Nugen Technologies, San Carlos, CA, USA). After library preparation with TruSeq DNA Sample Prep kit (Illumina, Madison, WI, USA), sequencing was performed on an Illumina HiSEqn 2000. Galaxy and Chipster open web-based platforms were used to analyse the data. We identified 49 differentially expressed genes. Heifers’ oocytes mRNA pattern indicated greater potential to sustain cell division. In particular, oocytes expressed more Keratin 14 (a gene involved in cell proliferation) and kinesin family member 20B (a protein involved in cytokinesis). More competent oocytes also have a greater ability to repair single-strand breaks due to the high levels of endo/exonuclease (5′-3′), endonuclease G-like. This may reflect greater capacity to neutralise DNA damage and, therefore, greater ability to preserve and transmit high-quality DNA. Repeat breeders portray a different landscape; their greater expression of Jun oncogene, Heat shock protein 1, Stimulated by retinoic acid gene6, arylhydrocarbon receptor nuclear translocator, fibromodulin, and aryl-hydrocarbon receptor repressor suggest that these oocytes have been subjected to environmental stress during oocyte maturation. Their greater expressions of inhibin α, stearoyl-CoA desaturase, junctional adhesion molecule 2 have been previously shown to correlate with a reduced oocyte developmental potential. Furthermore, the Cannabinoid receptor protein 1 expression suggests a compromised ion function that can lead to a failed activation of the development program. Finally, the greater expression of Ubiquilin3 and Heat shock protein 1 led to high protein and mRNA degradation, respectively, suggesting that these oocytes are deprived of essential components to sustain embryo growth. In conclusion our data provide the first detailed snapshot of the mRNA pattern defining the differences between a competent oocyte and an incompetent oocyte in vivo. Study supported by PRIN 2008, 2009 and EU-Quantomics.
APA, Harvard, Vancouver, ISO, and other styles
2

Pinato, David James, Francesco A. Mauri, Paolo Spina, Owen Cain, Abdul Siddique, Robert D. Goldin, Stephane Victor, et al. "Quantitative comparison of PD-L1 immuno-histochemical assays in hepatocellular carcinoma: The Blueprint-HCC study." Journal of Clinical Oncology 36, no. 5_suppl (February 10, 2018): 91. http://dx.doi.org/10.1200/jco.2018.36.5_suppl.91.

Full text
Abstract:
91 Background: Programmed cell death ligand 1 (PD-L1) expression by immunohistochemistry (IHC) enriches for responses to PD-1/PD-L1 inhibitors, however its role as a predictive biomarker in hepatocellular carcinoma (HCC) is inconclusive, with no consensus on any particular assay. We evaluated the performance of 4 different PD-L1 detection assays previously published in landmark clinical studies. Methods: PD-L1 IHC was performed on 4 serial sections from tissue microarray (TMA) blocks containing 100 archival cases of HCC that included tumour and surrounding non-tumorous tissue. Antibody clones E1LN3, 28-8, 22c3, SP263 were compared on the basis of percentage and intensity of staining in malignant cells (M) to generate an H-score (range 0-300). Immune cells infiltrating (ICI) and at the periphery, in non-tumorous tissue (ICP) were scored on a 4-tier system (0-3). Results: Patients were 76% males, 20% HCV-positive, 64% cirrhotic with a median age of 67 years. Median tumour size was 4 cm, 70% of patients had T1-T2 tumours and 48% were of grade 2. The proportion of PD-L1 positive cases according to M-ICI-ICP pattern was 2-6-2% for E1LN3, 10-18-19% for 28-8, 9-22-18% for 22c3 and 5-14-13% for SP263. Pairwise comparison of M H-scores revealed heterogeneity across antibodies, with highest concordance between E1L3N/SP263 (R2 = 0.95), E1L3N/22c3 (R2 = 0.65), 22c3/SP263 (R2 = 0.66) and increasing discordance for 28-8/22c3 (R2 = 0.44), E1L3N/28-8 (R2 = 0.29), and 28-8/SP263 (R2 = 0.26). Detection of PD-L1-positive immune infiltrates using a semi-quantitative scoring system revealed significantly different scores in pairwise non-parametric comparisons of ICI (p < 0.05) but not ICP (p > 0.05 for chi-square test). Conclusions: In the Blueprint-HCC study we demonstrated that quantification of PD-L1 protein levels in tumour cells, intra-tumoural and peri-tumoural infiltrate is characterised by inter-assay discordance in HCC. This has profound implications in the clinical development of predictive correlates of efficacy to immunotherapy in HCC. Sources of such discordance should be explored.
APA, Harvard, Vancouver, ISO, and other styles
3

Roper, Michael. "Effective Knowledge Management: A Best Practice Blueprint20036Sultan Kermally. Effective Knowledge Management: A Best Practice Blueprint. Chichester: John Wiley & Sons 2002. 194 pp., ISBN: ISBN 0 470 844493 3 £24.95." Journal of Documentation 59, no. 1 (February 2003): 118–19. http://dx.doi.org/10.1108/00220410310458082.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Othman, Zarith Sofiah, Nurhuda Ismail, Ahmad Khudzairi Khalid, and Norbaiti Tukiman. "Module Development for STEM Education Achievement: A Case Study at the Secondary School Level." Journal of Computational and Theoretical Nanoscience 17, no. 2 (February 1, 2020): 1085–89. http://dx.doi.org/10.1166/jctn.2020.8771.

Full text
Abstract:
STEM Education through the Malaysia Education Blueprint 2013–2025 (PPPM 2013–2025) is an important agenda in the transformation of education to prepare the younger generation for the challenges of the 21st century. Over the years, STEM was carried out, but there are still some issues which contribute towards the failure in achieving a policy percentage set of 60% science and 40% literary studies in secondary schools. The target to increase the number of Science students was not achieved. Therefore, this study was conducted to produce a STEM@IDEAS module as an alternative to increase students’ interest and understanding in solving the synopsis of learning in science, technology and mathematics (STEM). The module STEM@IDEAS focuses in competition design and generating prototype products through a variety of synopsis statements. STEM practices provide students with various trainings such as application of knowledge, skills and assessment to solve synopsis. This study has five (5) STEM practice steps and a total of three (3) modules which will be applied using the STEM elements. Furthermore, the STEM@IDEAS module was tested on several groups of four secondary school students around Pasir Gudang, Johor. A questionnaire was used to evaluate if STEM@IDEAS modules are in line with STEM and its impact on students. This survey uses a Likert scale of 0 to 4 to evaluate starting from 0 (strongly disagree) up to 4 (strongly agree) for each question submitted in each section. The STEM@IDEAS module and the above study are expected to be a source of interest and an alternative way for schools to support the nation’s education policy in strengthening the education development plans towards the nation’s progress.
APA, Harvard, Vancouver, ISO, and other styles
5

Maggio, Meg. "The Hong Kong Basic Law: Blueprint for “Stability and Prosperity” under Chinese Sovereignty? Edited by Ming K. Chan and David J. Clark. [New York: M. E. Sharpe, 1991. 310 pp. ISBN 0-87332-835-3.]." China Quarterly 153 (March 1998): 169–71. http://dx.doi.org/10.1017/s030574100000312x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Robinson, JoAnn L. "A Blueprint for the Promotion of Prosocial Behavior in Early Childhood. E. Chesebrough, P. King, T. P. Gullotta, & M. Bloom (Eds.). New York: Springer, 2004, $65.00 (Hardcover), 320 pp., ISBN 0-30648-186-3." Journal of Primary Prevention 27, no. 4 (June 24, 2006): 445–46. http://dx.doi.org/10.1007/s10935-006-0044-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Gotlib, Jason, Deepti H. Radia, Tracy I. George, William A. Robinson, Albert T. Quiery, Mark W. Drummond, Prithviraj Bose, et al. "Pure Pathologic Response Is Associated with Improved Overall Survival in Patients with Advanced Systemic Mastocytosis Receiving Avapritinib in the Phase I EXPLORER Study." Blood 136, Supplement 1 (November 5, 2020): 37–38. http://dx.doi.org/10.1182/blood-2020-137413.

Full text
Abstract:
Introduction: Advanced systemic mastocytosis (AdvSM) comprises a heterogeneous group of clonal mast cell neoplasms, primarily driven by KIT D816V. Measures of AdvSM response, including the International Working-Group for Myeloproliferative Neoplasms Research and Treatment and European Competence Network on Mastocytosis (IWG-MRT-ECNM) criteria, are based on improvements in mast cell-related organ damage (C-findings), and further sub-classified by the extent of reduction in measures of mast cell disease (e.g. serum tryptase level, bone marrow mast cell burden). However, assessment of some C-findings lacks precision (such as splenomegaly and its resolution). Normalization of C-findings may not be an adequate surrogate for important clinical outcomes such as overall survival (OS). We evaluated whether pure pathologic response (PPR) criteria based on changes in bone marrow mast cells, serum tryptase, and complete blood count was more closely correlated with OS compared to the modified IWG-MRT-ECNM (mIWG-MRT-ECNM) criteria. Methods: As an exploratory post-hoc analysis of the phase 1 EXPLORER study of avapritinib in AdvSM, we evaluated responses lasting ≥12 weeks by both mIWG-MRT-ECNM and PPR criteria. At baseline, evaluability for mIWG-MRT-ECNM response required ≥1 evaluable C-findings; PPR required presence of bone marrow mast cell aggregates and/or serum tryptase ≥20 ng/mL. Per PPR, morphologic complete remission (mCR) is absence of bone marrow mast cell aggregates, serum tryptase &lt;20 ng/mL and full (or partial [mCRh]) hematologic recovery; morphologic partial remission (mPR) is ≥50% reduction in bone marrow mast cells and serum tryptase level. OS was analyzed by Kaplan-Meier method and was time from first dose to death. OS comparisons were by log-rank test, performed for best response and landmark analyses at various cycles. Results: As of the data cut-off of August 30, 2019, 80 patients enrolled including 62 with AdvSM (7 with aggressive SM [ASM], 44 SM with an associated hematologic neoplasm [SM-AHN] and 11 with mast cell leukemia [MCL]). Ten (16%) AdvSM patients (7 ASM, 3 SM-AHN) were not response evaluable (RE) per mIWG-MRT-ECNM criteria, due to a lack of an evaluable C-finding at baseline, and 4 additional AdvSM patients were recently enrolled and were not yet response evaluable. Of the 48 RE patients (3 ASM, 35 SM-AHN and 10 MCL) the best overall response rate (ORR) per mIWG-MRT-ECNM was 77% (8% CR, 19% CRh, 42% partial response [PR], and 8% clinical improvement [CI]). Non-responders had stable disease (SD; 21%) or were not evaluable (NE) due to insufficient (&lt;13 weeks) follow-up (2%). Responders (CR/CRh/PR/CI) had 18-month OS of 85% (CR/CRh, 100%; PR, 77%; CI, 75%; Figure 1A); non-responders had 18-month OS of 48% (SD, 53%; NE, 0%) (P=0.042). Per PPR criteria, the best ORR was similar at 79%; however, a greater proportion of patients were assessed as being in a complete remission (15% mCR, 27% mCRh and 38% mPR). Non-responders by PPR all had SD (21%). This demonstrates that elimination of measurable mast cell burden can be discordant with complete C-finding resolution. Responders (mCR/mCRh/mPR) by PPR had 18-month OS of 88% (mCR/mCRh: 100%; mPR: 72%; Figure 1B); non-responders (all SD) had 18-month OS of 21% (P=0.0001). Eventually, all 62 AdvSM patients will be evaluable by PPR criteria, including those 10 patients without mIWG evaluable C-findings at baseline; however, 5 patients had insufficient follow-up at the time of analysis. For the 57 AdvSM patients with sufficient follow up, the best ORR per PPR criteria was similar at 77% (14% mCR, 26% mCRh and 37% mPR). Overall, no patients had a best response of progressive disease based on mIWG or PPR criteria. Landmark analyses of PPR at the end of 6 cycles showed a trend in 18-month OS of mCR/mCRh&gt;mPR&gt;SD in patients with similar starting avapritinib doses of ≥200 mg daily (n=48 of 57 PPR-evaluable patients). Conclusions : In the phase I EXPLORER study, response assessment in AdvSM using PPR criteria increases the evaluable population, significantly correlates with OS, and should be explored as a potential primary endpoint for future trials. Disclosures Gotlib: Blueprint Medicines Corporation: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: Chair of the Response Adjudication Committee and Research Funding, Research Funding; Deciphera: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: co-chair of the Study Steering Committee and Research Funding. Radia:Blueprint Medicines Corporation: Membership on an entity's Board of Directors or advisory committees; Novartis: Membership on an entity's Board of Directors or advisory committees, Other: Education events. George:Blueprint Medicines Corporation: Consultancy, Other: I have received no funding for this research. ARUP Laboratories, owned by the University of Utah, has received funding; Allakos: Consultancy; Deciphera: Other: consultancy, but has received no financial compensation for the past 12 months; Celgene: Consultancy. Robinson:Blueprint Medicines Corporation: Research Funding. Drummond:Jazz: Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Pfizer: Consultancy, Membership on an entity's Board of Directors or advisory committees; Novartis: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Research Funding, Speakers Bureau; Gilead: Membership on an entity's Board of Directors or advisory committees; Bristol Myers Squibb: Honoraria, Membership on an entity's Board of Directors or advisory committees, Speakers Bureau; Takeda: Membership on an entity's Board of Directors or advisory committees; Astellas: Membership on an entity's Board of Directors or advisory committees; Blueprint Medicine Corporation: Research Funding. Bose:Incyte Corporation: Consultancy, Honoraria, Research Funding, Speakers Bureau; Kartos Therapeutics: Honoraria, Research Funding; Astellas Pharmaceuticals: Research Funding; NS Pharma: Research Funding; Pfizer, Inc.: Research Funding; Promedior, Inc.: Research Funding; Constellation Pharmaceuticals: Research Funding; Celgene Corporation: Honoraria, Research Funding; CTI BioPharma: Honoraria, Research Funding; Blueprint Medicines Corporation: Honoraria, Research Funding. Hexner:Samus Therapeutics: Research Funding; Novartis: Research Funding; American Board of Internal Medicine: Other: member of the hematology exam committee; Blueprint Medicines Corporation: Other: serves on a data safety monitoring committee, Research Funding. Winton:Blueprint Medicines Corporation: Research Funding; Samus Therapeutics: Research Funding; Incyte Corporation: Research Funding. Horny:Novartis: Consultancy; Blueprint Medicines Corporation: Consultancy. Tugnait:Blueprint Medicines Corporation: Current equity holder in publicly-traded company, Ended employment in the past 24 months. Schmidt-Kittler:Blueprint Medicines Corporation: Current equity holder in publicly-traded company, Ended employment in the past 24 months. Evans:Blueprint Medicines Corporation: Current equity holder in publicly-traded company, Ended employment in the past 24 months. Lin:Blueprint Medicines Corporation: Current Employment, Current equity holder in publicly-traded company. Mar:Blueprint Medicines Corporation: Current Employment, Current equity holder in publicly-traded company. Deininger:Leukemia & Lymphoma Society: Research Funding; Bristol-Myers Squibb: Consultancy, Honoraria, Other, Research Funding; Ariad: Consultancy, Honoraria, Other; Incyte: Consultancy, Honoraria, Other, Research Funding; Novartis: Consultancy, Other, Research Funding; Medscape: Consultancy; Takeda: Consultancy, Membership on an entity's Board of Directors or advisory committees, Research Funding; Fusion Pharma: Consultancy; Blueprint Medicines Corporation: Consultancy, Honoraria, Membership on an entity's Board of Directors or advisory committees, Other: part of a study management committee, Research Funding; DisperSol: Consultancy; Galena: Consultancy, Honoraria, Other; Celgene: Research Funding; Gilead Sciences: Research Funding; SPARC: Research Funding; Sangamo: Consultancy, Membership on an entity's Board of Directors or advisory committees; Pfizer: Honoraria, Other, Research Funding. DeAngelo:Incyte Corporation: Consultancy; Glycomimetics: Research Funding; Forty-Seven: Consultancy; Amgen: Consultancy; Novartis: Consultancy, Research Funding; Pfizer: Consultancy; Abbvie: Research Funding; Jazz: Consultancy; Autolos: Consultancy; Shire: Consultancy; Takeda: Consultancy; Blueprint Medicines Corporation: Consultancy, Research Funding; Agios: Consultancy.
APA, Harvard, Vancouver, ISO, and other styles
8

Maltin, C. A., G. E. Lobley, C. M. Grant, L. A. Miller, D. J. Kyle, G. W. Horgan, K. R. Matthews, and K. D. Sinclair. "Factors influencing beef eating quality 2. Effects of nutritional regimen and genotype on muscle fibre characteristics." Animal Science 72, no. 2 (January 2001): 279–87. http://dx.doi.org/10.1017/s1357729800055776.

Full text
Abstract:
AbstractEighteen purebred steers of three genotypes, Aberdeen Angus (AA), Charolais (CH) and Holstein (HO), were divided within genotype into three groups of six animals and offered one of three different levels of feeding either moderate (M/M) or high (H/H) both for 20 weeks or moderate for the first 10 weeks followed by high for the remaining 10 weeks (M/H). Growth rates during the final 10 weeks of the experimental period differed between dietary regimen (M/M = 0·87; M/H = 1·25; and H/H = 1·02 kg/day; s.e.d. = 0·08;P< 0·001). Over the entire 20 week experimental period animals offered the M/M level of feeding grew more slowly (0·97 kg/day) than those offered the M/H and H/H level of feeding (1·20 kg/day; s.e.d. = 0·06;P< 0·001). Mean growth rates for CH, HO and AA steers were 1·21, 1·13 and 1·03 kg/day (s.e.d. = 0·06;P< 0·05). The animals were all slaughtered at a fixed age of 18 months, according to the Meat and Livestock Commission Blueprint for beef and, 48 h post mortem, samples of m. longissimus lumborum (LL) and m. vastus lateralis (VL) were removed for analyses.Muscle fibres were classified histochemically, according to their contractile and metabolic properties, and muscle fibre size was measured. Fibre type frequency was calculated and, in LL, the total fibre number of the muscle was estimated. There was little impact of feeding level, or consequentially growth rate, on muscle fibre frequency and size. The effects seen were confined mainly to LL where there were significant differences between the M/M and H/ H groups with respect to fast twitch glycolytic fibres (mean % frequency (M/M = 40·1 and H/H = 44·3; s.e.d. = 1·4;P< 0·01); mean % area (M/M = 51·9 and H/H 56·0; s.e.d. = 1·5;P< 0·05)) and apparent total fibre number (M/ M = 35·0; and H/H = 41·9 ✕ 104; s.e.d. = 1·7;P< 0·05) which were greater in H/H than in M/M groups. However, in both LL and VL the predominant differences were related to genotype; in particular, overall fibre size was smallest in CH, while slow oxidative (SO; type I) fibre area was highest in AA. For LL, analysis across all animals showed a positive relationship between SO area, % area, % frequency and overall acceptability of meat at 14 days as evaluated by a trained sensory panel. No such relationship was observed for VL. The data suggest that in this study manipulation of feeding level has only a small impact on muscle fibre characteristics and that the differences between genotype and muscle type may be more important in determining the variability of overall acceptability than growth rate.
APA, Harvard, Vancouver, ISO, and other styles
9

Gotlib, Jason R., Deepti Radia, Daniel J. DeAngelo, Prithviraj Bose, Mark W. Drummond, Elizabeth O. Hexner, William A. Robinson, et al. "Avapritinib, a Potent and Selective Inhibitor of KIT D816V, Improves Symptoms of Advanced Systemic Mastocytosis (AdvSM): Analyses of Patient Reported Outcomes (PROs) from the Phase 1 (EXPLORER) Study Using the (AdvSM) Symptom Assessment Form (AdvSM-SAF), a New PRO Questionnaire for (AdvSM)." Blood 132, Supplement 1 (November 29, 2018): 351. http://dx.doi.org/10.1182/blood-2018-99-112017.

Full text
Abstract:
Abstract Introduction: The KIT D816V oncogene is a key driver in 90-95% of patients with systemic mastocytosis (SM), a group of mast cell (MC) neoplasms including indolent SM (ISM), smoldering SM (SSM) and AdvSM. Debilitating symptoms related to MC proliferation and degranulation characterize ISM and SSM and are also prominent in AdvSM, which is further complicated by SM-related organ damage and decreased survival. Currently, there are no approved agents that selectively target KIT D816V, and there are limited tools to assess symptom improvement in SM. Avapritinib, a highly potent and selective inhibitor of the KIT D816V mutant, showed substantial clinical activity in AdvSM (83% overall response rate (ORR) per modified IWG-MRT-ECNM criteria) in the Phase 1 EXPLORER study [Deininger, et al, EHA, 2018]. We present results using a novel PRO questionnaire, the AdvSM-SAF, developed in accordance with FDA guidance, to assess changes in symptoms in the Part 2 dose expansion phase of EXPLORER. Methods: Patients (pts) received avapritinib at the recommended Phase 2 dose (300 mg once daily [QD]) in continuous 28-day (d) cycles. Pts completed the AdvSM-SAF and 2 additional PROs used in other cancers, the Patient Global Impression of Symptom Severity (PGIS) and the European Organization for Research and Treatment of Cancer Quality of Life (QLQ). PROs and KIT D816V mutant allele fraction (MAF) in blood were assessed serially as follows: AdvSM-SAF daily, from 7 d before first avapritinib dose, ie, baseline (BL: Cycle [C]1 Day [D]1) and through C12, using an electronic diary; PGIS and QLQ at BL (C1D1) and on D1 of each cycle through C12; and KIT D816V mutant allele fraction (MAF) at BL and on D1 of C3, 7, 11, and then every 6 cycles. The AdvSM-SAF assesses severity of 8 symptoms (pruritus, flushing, spots, nausea, vomiting, diarrhea, abdominal pain, fatigue) on a 0-10 scale, and 2 items assess frequency of diarrhea and vomiting. Results are analyzed as a Total Symptom Score (TSS), combining all 8 severity items (maximum symptom score=80), and as a GI domain (combining 4 symptoms: nausea, vomiting, diarrhea, abdominal pain; maximum score 40) and Skin domain (combining 3 symptoms: pruritus, flushing, spots; maximum score 30). Analyses were based on 7 d average scores. AdvSM-SAF data were summarized at BL (C1D-7 to C1D-1), and over the 7-d interval prior to C3D1 and C7D1, and correlated with QLQ, PGIS and KIT D816V MAF. Results: As of 22 June 2018, 25 pts were treated in Part 2 of the study; 24 are ongoing, and enrollment and follow-up continues. The median duration of avapritinib treatment was 5.7 mo (range, 1.7+ to 10.3+ mo). AdvSM-SAF scores for 24 pts with data are shown the Table. Mean BL TSS, GI and Skin scores were 22.6, 9.1, and 7.1. The most severe BL symptom was fatigue (mean score of 6.4). Among 21 pts with scores at C3D1 and 12 pts with scores at C7D1, mean reductions from BL TSS, GI and Skin scores were 6.4, 3.9, and 1.5 points, and 11.1, 5.7, and 4.4 points, respectively, indicating further improvement with continued treatment. Symptom reductions were seen for all 8 items at C3D1. Further symptom improvement was observed for 6 of 8 items from C3D1 to C7D1. Reductions in AdvSM-SAF TSS, GI and Skin scores significantly correlated with improvement in QLQ Emotional (EF) and Cognitive functioning (CF) scales (p values for Pearson Correlation Coefficients <0.0001, <0.0001, and 0.04 with EF and <0.0001, 0.0001, and 0.04 with CF, respectively). Among 18 pts with BL PGIS (mean 3.2, SD 1.15, range 1-5), improvement in PGIS was highly associated with improvement in GI score (p value 0.0004). Decreases in KIT D816V MAF correlated with reduction in TSS (p value 0.04). Conclusions: Avapritinib treatment resulted in meaningful symptom improvement as measured by the AdvSM-SAF in overall symptoms (TSS), GI and skin domains, and all individual symptoms, and improvement continued with longer duration of treatment. Reduction in AdvSM-SAF scores correlated with improvements in other PRO instruments, PGIS and QLQ, supporting the AdvSM-SAF as a useful new tool to assess symptoms in pts with AdvSM. Reduction in AdvSM-SAF scores also correlated with decreases in KIT D816V MAF, indicating that reductions in disease burden may correlate with reduced disease symptoms and improved quality of life. These data warrant further development of avapritinib in AdvSM, as well as in ISM and SSM where symptom burden and poor quality of life are the predominant disease manifestations. Disclosures Gotlib: Deciphera: Consultancy, Honoraria, Research Funding; Blueprint Medicines: Consultancy, Honoraria, Research Funding; Novartis: Consultancy, Honoraria, Research Funding; Promedior: Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Kartos: Consultancy; Incyte: Consultancy, Honoraria, Research Funding; Gilead: Consultancy, Research Funding. Radia:Novartis: Speakers Bureau; Blueprint: Consultancy. DeAngelo:Glycomimetics: Research Funding; Shire: Honoraria; Pfizer Inc: Consultancy, Honoraria; Incyte: Consultancy, Honoraria; Amgen: Consultancy; Novartis Pharmaceuticals Corporation: Consultancy, Honoraria; Takeda: Honoraria; ARIAD: Consultancy, Research Funding; BMS: Consultancy; Blueprint Medicines: Honoraria, Research Funding. Bose:CTI BioPharma: Research Funding; Celgene Corporation: Honoraria, Research Funding; Pfizer, Inc.: Research Funding; Blueprint Medicines Corporation: Research Funding; Incyte Corporation: Honoraria, Research Funding; Astellas Pharmaceuticals: Research Funding; Constellation Pharmaceuticals: Research Funding. Conlan:Blueprint Medicines: Employment. Oren:Blueprint Medicines: Employment. Shi:Blueprint Medicines: Employment. Deininger:Pfizer: Consultancy, Membership on an entity's Board of Directors or advisory committees; Blueprint: Consultancy.
APA, Harvard, Vancouver, ISO, and other styles
10

Goodhart, William. "The Hong Kong Basic Law—Blueprint for “Stability and Prosperity” under Chinese Sovereignty?. Edited by Ming K. Chan and David J. Clark. [New York: M. E.Sharpe East Gate Books. 1991. xv + 310 pp. ISBN 0-87332-835-3. $45]." International and Comparative Law Quarterly 41, no. 4 (October 1992): 963–64. http://dx.doi.org/10.1093/iclqaj/41.4.963.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Blueprint A 3.0"

1

Bikanga, Raphaël. "Proprietes tensioactives de derives 3-0-acyle, 3-0-alkyle et 3-desoxy-3-s-alkyle du d-glucose." Amiens, 1993. http://www.theses.fr/1993AMIES003.

Full text
Abstract:
Nous avons etudie une nouvelle gamme de tensioactifs non-ioniques comprenant 24 derives amphiphiles du d-glucose, du type 3-zr-1,2-0-isopiopylidene--d-glucofuranose (a) et du type 3-zr-d-glucopyranose (b) dans lesquels z=0c0 ; 0 ; s et r=c#nh#2#n#+#1, avec 7n8. Les concentrations micellaires critiques (c. M. C. ) dans l'eau, a 25c, varient de 2 a 40 micromoles/l pour les composes de la famille (a) et de 40 a 200 micromoles/l pour les composes de la famille (b). L'etude de la variation de la c. M. C. En fonction de la temperature et de la longueur de la chaine r, a permis d'acceder aux grandeurs thermodynamiques de micellisation et de montrer que les micelles de la famille (a) sont plus stables que celles de la famille (b). Les rapports hydrophilie/lipophilie (hlb) ont ete determines par la mesure des constantes dielectriques ou par la formulation d'emulsions stables avec un cotensioactif. La seconde methode donne des valeurs coherentes avec le nombre de groupements oh libres. Elle montre aussi que dans chaque famille, le hlb est independant du type de jonction z de la chaine alkyle, mais varie lineairement avec le nombre d'atomes de carbone de cette chaine. Dans cette correlation, la pente de la droite pour la famille (a) est le double de celle obtenue pour la famille (b). L'etude des diagrammes de phases e-h-ta et e-h-ta+cota revele l'existence des domaines monophasiques correspondant a des phases transparentes, a des emulsions bleutees ou blanches et a des gels. Les coordonnees de ces domaines varient avec la temperature et les parametres structuraux z, r, nombre de groupements oh libres. Des formulations stables ont ete obtenues sous forme d'emulsions a action antimousse et de gels pour la cosmetologie (cires epilatoires)
APA, Harvard, Vancouver, ISO, and other styles
2

REVERSAT, LUC. "Proprietes magnetiques, conductrices et optiques d'oxydes de manganese a magnetoresistance colossale deposes en films minces : la 0 . 6 7sr 0 . 3 3mno 3 et pr 0 . 6ca 0 . 4mno 3." Paris 11, 2001. http://www.theses.fr/2001PA112129.

Full text
Abstract:
La magnetoresistance colossale, decouverte en 1994 sur les oxydes de manganese a valence mixte, les manganites, a declenche un engouement rare dans la monde entier. Le compose la 0. 6 7sr 0. 3 3mno 3 est demi-metallique parfait a basse temperature et possede la temperature de curie la plus elevee des manganites ; ceci en fait le support ideal pour les magnetoresistances tunnel et l'electronique de spin. Le compose pr 1 - xca xmno 3 (x=0. 3 a 0. 5) presentent a basse temperature un etat isolant antiferromagnetique d'ordre de charges. Un champ magnetique applique induit un etat ferromagnetique metallique. Dans ce contexte, nous avons choisi de nous consacrer a la caracterisation de films minces de la 0. 6 7sr 0. 3 3mno 3 (lsmo) et de pr 0. 6ca 0. 4mno 3 (pcmo). A partir de films de lsmo elabores par ablation laser et par mocvd, j'ai realise un ensemble de caracterisations structurales, magnetiques et de transport a des epaisseurs variables permettant de comparer les deux methodes de depot et de determiner dans quelles limites d'epaisseur on obtient les meilleurs proprietes (epitaxie, temperature de curie, resistivite). Je montre que la resistivite de lsmo est quasiment constante de 0 hz a 35 ghz, malgre une contribution inductive, de l'ordre de quelques % de la partie reelle de l'impedance a 35ghz. La reflectivite montre un comportement conducteur jusqu'au lointain infrarouge a temperature ambiante et jusqu'au moyen infrarouge a basse temperature. L'effet kerr magneto-optique est important dans certaines gammes de longueur d'onde. Les films minces de pcmo les plus epais et l'assemblage pcmo/lsmo-monocristallin presentent la transition isolant-metal mais elle est peu abrupte. L'assemblage pcmo/lsmo/substrat demeure isolant. Nous avons observe la transition isolant-metal optiquement sur un film mince grace a un systeme de mesure optique en champ et temperature ajustable. La reflectivite diminue lorsque l'echantillon devient ferromagnetique metallique mais de facon moins abrupte que la resistivite.
APA, Harvard, Vancouver, ISO, and other styles
3

LALLEMENT, ALEXANDRA. "Spectroscopie et collisions baryum+molecules dans des gros agregats d'argon ar#3#0#0-ar#4#0#0#0." Paris 11, 1993. http://www.theses.fr/1993PA112045.

Full text
Abstract:
Ce travail presente une etude de gros agregats d'argon comme support pour des processus reactifs ou non reactifs impliquant un atome de baryum et des molecules. Ceux-ci sont fixes aux agregats par collision dans un dispositif de faisceaux croises. On a developpe des methodes de caracterisation permettant de mesurer la taille et la composition des gros agregats. L'etude spectroscopique du baryum implante dans l'agregat d'argon montre que le baryum reste en surface de l'agregat. Quand l'agregat contient en plus des molecules (ch#4, nh#3, sf#6,. . . ), cette meme etude montre que le baryum excite electroniquement est deexcite non radiativement par collision. Ceci est interprete par une mobilite importante en surface de l'agregat. Enfin, l'agregat d'argon est etudie comme milieu reactionnel sur la reaction chimiluminescente ba+n#2o. L'agregat d'argon se revele etre un milieu intermediaire entre la phase gazeuse et les phases condensees. Des proprietes propres a l'agregat du fait de sa taille finie ont ete mises en evidence: possibilite pour les produits de reaction de quitter l'environnement d'argon, augmentation de section efficace de reaction
APA, Harvard, Vancouver, ISO, and other styles
4

EL, HARRAD IMAD CARABATOS CONSTANTIN. "CONTRIBUTION A L'ETUDE STRUCTURALE ET SPECTROSCOPIQUE DE CERAMIQUES PEROVSKITES PLZT : (PB#1##3#X#/#2LA#X@#X#/#2)(ZR#0#,#9#5TI#0#,#0#5)O#3 (X=0,01 A 0,08) ET PZTN: PB#0#,#9#9(ZR#0#,#9#5TI#0#,#0#5)#0#,#9#7NB#0#,#0#2#5O#3 ET DE LEURS TRANSITIONS DE PHASES /." [S.l.] : [s.n.], 1994. ftp://ftp.scd.univ-metz.fr/pub/Theses/1994/El_Harrad.Imad.SMZ9419.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Peles, Amra. "Field-dependent magnetic and transport properties and anisotropic magnetoresistance in ceramic La¦0¦.¦6¦7Pb¦0¦.¦3¦3MnO¦3." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape9/PQDD_0007/MQ45107.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Shan, Xiaobing Cheng Zhongyang. "High dielectric constant 0-3 ceramic-polymer composites." Auburn, Ala, 2009. http://hdl.handle.net/10415/1820.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sandström, Evelina, and Alexandra Wiberg. "Framtagning av joystick för barn 0-3 år." Thesis, Mittuniversitetet, Avdelningen för naturvetenskap, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:miun:diva-35731.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Quenneville, Éric. "Propriétés électroniques des couches minces de La¦0[indice],¦5Sr¦0[indice],¦5MnO¦3." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1999. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape8/PQDD_0015/MQ48869.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Trévisiol, Pascale. "Problèmes de référence dans la construction du discours par des apprenants japonais du français, langue 3." Paris 8, 2003. http://octaviana.fr/document/134104560#?c=0&m=0&s=0&cv=0.

Full text
Abstract:
Cette thèse traite de l'acquisition guidée d'une langue 3 (L3) par des apprenants japonais du français (débutants, intermédiaires, avancés) dans une perspective fonctionnelle. L'étude porte sur la façon dont ces locuteurs expriment la référence à 3 domaines conceptuels de base (entités, temps, espace) dans la construction d'un discours narratif (récit de film). L'organisation et l'expression de la temporalité, de la spatialité et de la référence aux entités, ainsi que son développement d'un groupe de niveau à l'autre, sont étudiés à travers l'analyse de la production langagière des apprenants. La question de l'influence de la langue maternelle et/ou d'une autre langue étrangère (anglais L2) est également posée : la comparaison des données d'apprenants avec celles de locuteurs natifs japonophones face à la même tâche discursive permet de mieux cerner le rôle et le poids respectifs de la L1 et de la L2, ainsi que les conditions autorisant le transfert de connaissances antérieures en L3
This thesis deals with the instructed acquisition of French as a 3rd language (L3) by Japanese learners (initial, intermediate, advanced) from a functional point of view. The study investigates the way in which learners refer to 3 basic conceptual categories (entities, time, space) in the construction of a narrative (film retelling). These productions form the basis for an analysis of the expression and organization of temporality, spatiality and reference to entities, as well as its development from a group of level to another. Also studied is the question of the influence of mother tongue and/or another foreign language (english L2) : the comparison of the learners' data with those of Japanese native speakers in the same task makes it possible better to determine the respective role and weight of L1 and L2, as well as the conditions allowing the transfer of former knowledge in L3 production
APA, Harvard, Vancouver, ISO, and other styles
10

Moreno, Sierra César. "New features in solution derived La(0:7)Sr(0:3)MnO(3) thin films : spontaneous outcropping and nanoscale reversible resistive switching." Doctoral thesis, Universitat Autònoma de Barcelona, 2010. http://hdl.handle.net/10803/3424.

Full text
Abstract:
Esta disertación describe las propiedades estructurales, de transporte electrónico y magnéticas básicas de películas delgadas de La0.7Sr0.3Mn03 (LSMO) crecidas por depósito de soluciones químicas en substratos monocristalinos. Además, nuevas características, tales como, el afloramiento espontáneo de puntos nanométricos aislantes en la superficie de la película de LSMO e interruptores resistivos reversibles a la nano escala han sido abordados.
Esta tesis está organizada del siguiente modo: primero, se da una breve introducción sobre manganitas. En el segundo capítulo, el estudio de un nuevo mecanismo para generar estructuras aislantes y nanométricas auto-ensambladas en la superficie de la película de LSMO es presentado. Estas dos fases cristalinas, la película delgada de LSMO y los puntos aislantes, son investigados por microscopía electrónica de transmisión (TEM), mostrando una estructura coherentemente tensionada, si bien el estado de tensión y la simetría de la red de la capa de LSMO debajo de los puntos ha sido modificada. Estas islas aislantes provocan una tensión isotrópica a la película debajo de las mismas, lo cual, hace disminuir la contribución magneto-elástica en la anisotropía magnética. Se muestra que el tamaño y la concentración de las islas puede ser modificado a través de la cinética del crecimiento y modificando la cantidad de exceso de La en la solución precursora inicial.
En el tercer capítulo, se intenta poner en evidencia el papel que juega la generación de tensión en las interficies así como su acomodación cuando se cambian las propiedades de la película delgada. Por este motivo, la dependencia de la propiedades de magneto transporte han sido analizadas. Los cambios de estas propiedades han sido examinados en el marco de un modelo magneto elástico, encontrando que dichos cambios no pueden ser justificados solamente con el estado de tensión. Sino que, la temperatura de transición de Curie y metal-aislante están influenciadas por otros factores como pueden ser inhomogeneidades químicas y desorden estructural presente en la película delgada.
En el cuarto capitulo, con el fin de dilucidar el origen del calentamiento debido a efecto Joule, si se trata de un efecto intrínseco o extrínseco, en la biestabilidad resistiva de las películas delgadas de LSMO hemos llevado a cabo un estudio detallado del origen de este calentamiento. Presentamos medidas del transporte electrónico macroscópicas y locales obtenidas con un microscopio de sonda local en modo detección de corriente (C-SFM). Demostramos que, bajo adecuadas condiciones de medida, el régimen de resistencia biestable no puede ser conseguido a una temperatura de 300K. Además, sugerimos que este fenómeno sólo podría ser alcanzado en películas delgadas de LSMO a temperaturas entorno a 250K.
En el quinto capítulo, una nueva metodología basada en la generación de estados resistivos esta¬bles, capaz de programar, almacenar y leer múltiples niveles de información en regiones nanométri¬cas fue llevada a cabo modificando las propiedades resistivas intrínsecas de las películas delgadas de LSMO. Demostramos que el número de estos diferentes niveles puede llegar al menos a 10 pudiendo ser incluso mayor. Con este concepto de memoria resolvemos algunos de los principales escollos de la memorias resistivas de acceso aleatorio (RRAM), salvo en el conocimiento del mecanismo que gobierna, como son la escalabilidad, el bajo coste de producción, una alta densidad de almacenaje de datos y la uniformidad espacial del interruptor resistivo.
Las técnicas y procedimientos experimentales usados en esta tesis son presentados en el capítulo 7. Tanto la técnica de crecimiento de las películas epitaxiales, depósito de soluciones químicas, como la síntesis de las muestras es descrita. También se explican las diferentes técnicas utilizadas para la caracterización química, estructural, de transporte eléctrico y propiedades magnéticas. Además, el proceso de litografía óptica empleado para las medidas de transporte electrónico se explica en este capítulo.
This dissertation describes the basic structural, electronic transport and magnetic properties of epitaxial La0.7Sr0.3Mn03 (LSMO) thin films on single crystalline substrates grown by chemical solution deposition. In addition, new features such as spontaneous outcropping of insulating nanodots on the LSMO surface and nanoscale reversible resistive switching have also been addressed.
The thesis is organized in the following way: first, a short introduction to manganites is given. In the second chapter, a study of the new mechanism for the creation of self-assembled insulating epitaxial nanostructures in a LSMO film surface is presented. These two crystalline phases, LSMO thin film and insulating nanodots, are investigated by transmission electron microscopy (TEM), displaying a coherently strained structure, even though the strain state and the lattice symmetry of the LSMO film underneath the islands have been modified. Insulating islands induce an isotropic strain to the LSMO film underneath the island which decreases the magnetoelastic contribution to the magnetic anisotropy. It is shown that the size and concentration of the nanodots can be tuned by means of growth kinetics and through modification of the La excess in the precursor chemical solution. Furthermore, nanoscale electrical analysis was performed by C-SFM in order to determine the insulating behavior of the nanodots.
In the third chapter, we report our efforts to give some insight into the role that interfacial strain generation and interfacial strain accommodation play on the thin film properties. On this account, the dependence of the LSMO films magnetoelectronic properties on the film thickness is scrutinized. The changes of the magnetoelectronic properties have been examined assuming a magnetoelastic model and we found that these changes on magnetoelectronic properties cannot be explained merely by the film strain state. Instead, the Curie and metal to insulator transition temperatures are also influenced by other factors, such as chemical inhomogeneities and structural disorder in the film.
In the fourth chapter, in order to elucidate the intrinsic or extrinsic origin of the Joule heating effect in the resistance bistability of LSMO thin films we accomplish a detailed study of the heating sources. We report macroscopic transport measurements and local electrical behavior at the nanoscale, obtained by conducting Scanning Force Microscopy (C-SFM). We have demonstrated that, under ad¬equate measuring conditions, a regime of bistable resistivity in LSMO thin films is not achieved at T = 300 K. We otherwise suggest that this phenomenon would only occur in LSMO films when measuring at temperatures below T ∽ 250 K.
In the fifth chapter, a new stable resistive switching based methodology capable to program, store and read out multiple levels in a nanoscale regions were performed modifying the intrinsic properties of the LSMO film. We demonstrate that the number of distinguishable resistance levels can readily reach 10 and even higher. We overcome the main handicaps of resistive random-access memory (RRAM) approaches, except for unclear driven mechanism of resistive switching, namely scalability, low cost, high area density of storage data and spatial uniformity of resistive switching process.
The experimental techniques and procedures used in this thesis are summarized in chapter 7. The growth technique of epitaxial thin film, chemical solution deposition, and the synthesis of samples are described. Also different chemical characterization, structural, electronic transport and magnetic techniques are presented. In addition, the optical lithography process employed for electronic trans¬port measurements is explained in this chapter.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Blueprint A 3.0"

1

Abbs, Brian. American blueprint 3. Harlow: Longman, 1994.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Cierpka, Manfred, ed. Frühe Kindheit 0 – 3. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-20296-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Orme, David. English language: A blueprint for key stage 3. Cheltenham: S. Thornes, 1995.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Harvey, Robert, ed. Blueprint 2000. London: Palgrave Macmillan UK, 1988. http://dx.doi.org/10.1007/978-1-349-19464-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Cierpka, Manfred, ed. Frühe Kindheit 0-3 Jahre. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-39602-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burberg, Jürgen, and Peter Schneiderlöchner. Microsoft® Excel 3. 0. Wiesbaden: Vieweg+Teubner Verlag, 1991. http://dx.doi.org/10.1007/978-3-663-14025-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Cierpka, Manfred, ed. Frühe Kindheit 0-3 Jahre. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-662-45742-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Andrew, Ladd, ed. SAP R/3 business blueprint: Understanding enterprise supply chain management. 2nd ed. Upper Saddle River, NJ: Prentice Hall PTR, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Vervaet, Ewald. Groeienderwijs: Psychologie van 0 tot 3. Amsterdam: Ambo, 2009.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Gerhard, Keller, and Ladd Andrew, eds. SAP R/3 business blueprint: Understanding the business process reference model. Upper Saddle River, N.J: Prentice Hall PTR, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Blueprint A 3.0"

1

Hollis, Norma T. "Inner Voice Blueprint." In Blueprint for Engagement, 11–30. New York : Taylor & Francis, [2018]: Productivity Press, 2018. http://dx.doi.org/10.4324/9781315180298-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Becker, Karl-Heinz, and Michael Dörfler. "BluePrint Offene Architektur." In System 7 Einsteigen leichtgemacht, 205–24. Wiesbaden: Vieweg+Teubner Verlag, 1993. http://dx.doi.org/10.1007/978-3-663-12389-7_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Latendorf, André Gilbert, Pauline Found, Jan Harwell, and Robin Howlett. "Digital Transformation Blueprint." In Neue Dimensionen der Mobilität, 793–813. Wiesbaden: Springer Fachmedien Wiesbaden, 2020. http://dx.doi.org/10.1007/978-3-658-29746-6_62.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Plattner, Hasso. "A Blueprint of SanssouciDB." In A Course in In-Memory Data Management, 29–33. Berlin, Heidelberg: Springer Berlin Heidelberg, 2013. http://dx.doi.org/10.1007/978-3-642-36524-9_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Johansson, Per-Olov, and Bengt Kriström. "Blueprint for a CBA." In The Economics of Evaluating Water Projects, 69–89. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-27670-5_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Dean, Jonathan. "Arms Reduction Blueprint (1991)." In Jonathan Dean, 166–73. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-06662-2_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Plattner, Hasso. "A Blueprint of SanssouciDB." In A Course in In-Memory Data Management, 33–36. Berlin, Heidelberg: Springer Berlin Heidelberg, 2014. http://dx.doi.org/10.1007/978-3-642-55270-0_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

McKay, Alison, and Saikat Kundu. "A Blueprint for Engineering Service Definition." In Complex Engineering Service Systems, 215–32. London: Springer London, 2011. http://dx.doi.org/10.1007/978-0-85729-189-9_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tobias, Michael Charles, and Jane Gray Morrison. "Bioeconomics: A New National Blueprint." In Why Life Matters, 97–98. Cham: Springer International Publishing, 2014. http://dx.doi.org/10.1007/978-3-319-07860-1_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Brooks, Erinn. "Complying Creatively with AAG’s Blueprint." In Education Reform in the Twenty-First Century, 115–47. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-61195-8_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Blueprint A 3.0"

1

Buch, Mads, and Steen Rasmussen. "Blueprint for Self-replicating and Self-assembling 3D Printers." In Artificial Life 14: International Conference on the Synthesis and Simulation of Living Systems. The MIT Press, 2014. http://dx.doi.org/10.7551/978-0-262-32621-6-ch159.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Pilgrim, S. M., and R. E. Newnham. "3-0: A New Composite Connectivity." In Sixth IEEE International Symposium on Applications of Ferroelectrics. IEEE, 1986. http://dx.doi.org/10.1109/isaf.1986.201149.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Lixin, Chen, Zhuang Guorung, and Mei Liangom. "Optical and electrical properties of In 2 0 2 /In, In 2 0 3 /Sn (ITO), In 2 0 3 /Cd." In 29th Annual Technical Symposium, edited by Richard A. Mollicone and Irving J. Spiro. SPIE, 1985. http://dx.doi.org/10.1117/12.950684.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Shibata, Ken-ichiro, H. Nakamura, and Akihito Fujii. "Nondoped Y 2 0 3 for 3-5μm IR transmission." In San Dieg - DL Tentative, edited by Paul Klocek. SPIE, 1990. http://dx.doi.org/10.1117/12.22480.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

"ISBN 0-7803-8909-3 [Back Cover]." In Proceedings of the IEEE INDICON 2004. First India Annual Conference, 2004. IEEE, 2004. http://dx.doi.org/10.1109/indico.2004.1497836.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jones, David G. "From 0 to 1,169,600 in 3 minutes." In Companion to the 22nd ACM SIGPLAN conference. New York, New York, USA: ACM Press, 2007. http://dx.doi.org/10.1145/1297846.1297857.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

"ISBN: 0-7803-8635-3 [Back Cover]." In Proceedings of the 2004 IEEE International Symposium on Intelligent Control. IEEE, 2004. http://dx.doi.org/10.1109/isic.2004.1387744.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Li, Zongjin, and Biqin Dong. "0-3 cement-based piezoelectric ceramic composites." In NDE for Health Monitoring and Diagnostics, edited by Tribikram Kundu. SPIE, 2003. http://dx.doi.org/10.1117/12.484068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Smith, M. A., C. P. Rinsland, V. M. Devi, J. M. Flaud, and C. Camy-Peyret. "Fourier-Transform Spectroscopy Of 0 3 In The 3 µm Region." In Intl Conf on Fourier and Computerized Infrared Spectroscopy, edited by David G. Cameron. SPIE, 1989. http://dx.doi.org/10.1117/12.969566.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Yao, Xi, Liangying Zhang, and Chunliang Liu. "0-3 nanocomposites for optoelectronics and nonlinear optics." In Optoelectronic Science and Engineering '94: International Conference, edited by Wang Da-Heng, Anna Consortini, and James B. Breckinridge. SPIE, 1994. http://dx.doi.org/10.1117/12.182142.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Blueprint A 3.0"

1

Newberg, H. J. M. Measuring q sub 0 using supernovae at z approx 0. 3. Office of Scientific and Technical Information (OSTI), July 1992. http://dx.doi.org/10.2172/6973084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

SECRETARY OF THE AIR FORCE WASHINGTON DC. Organization and Employment of Aerospace Power, This documents compliments Joint Pubs 0-2, 3-0, and 3-56.1. Fort Belvoir, VA: Defense Technical Information Center, February 2000. http://dx.doi.org/10.21236/ada408306.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

SECRETARY OF THE AIR FORCE WASHINGTON DC. Command and Control, AFDD2-8, This document compliments Joint Pubs 0-2, 3-30, 3-56-1, and 6-0. Fort Belvoir, VA: Defense Technical Information Center, February 2001. http://dx.doi.org/10.21236/ada407260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Niedermayer, M., D. Rice, and J. Martinez. FFV1 Video Coding Format Versions 0, 1, and 3. RFC Editor, August 2021. http://dx.doi.org/10.17487/rfc9043.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Flament, T. A. Thermal decomposition of UO{sub 3}-2H{sub 2}0. Office of Scientific and Technical Information (OSTI), February 1998. http://dx.doi.org/10.2172/362401.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Jantzen, C. M., and N. E. Bibler. Nuclear waste glass Product Consistency Test (PCT), Version 3. 0. Office of Scientific and Technical Information (OSTI), November 1990. http://dx.doi.org/10.2172/6017524.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Wurtz, Jeffrey, and Ken Rehfeldt. Completion Report for Well ER-3-3 Corrective Action Unit 97: Yucca Flat/Climax Mine, Revision 0. Office of Scientific and Technical Information (OSTI), April 2017. http://dx.doi.org/10.2172/1352936.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Zimmerman, Eric D. A Measurement of the Branching Ratio of $\pi^0 \to e^+ e^-$ Using $K_L \to 3\pi^0$ Decays in Flight. Office of Scientific and Technical Information (OSTI), January 1999. http://dx.doi.org/10.2172/1421517.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Muller, Isabelle S., Keith S. Matlack, Ian L. Pegg, and Innocent Joseph. Final Report: Enhanced LAW Glass Correlation - Phase 3, VSL-17R4230-1, Rev 0. Office of Scientific and Technical Information (OSTI), November 2017. http://dx.doi.org/10.2172/1512925.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Martian, P., and J. N. Chung. Independent verification and validation testing of the FLASH computer code, Versiion 3. 0. Office of Scientific and Technical Information (OSTI), June 1992. http://dx.doi.org/10.2172/7288831.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Blueprint A 3.0' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography